Similarly, the PPOS group in RCTs ( 15 , 16 , 33 ) showed an increasing trend of Gn dose (MD = 179.57, 95% CI: -235.39-594.52 IU, I 2 = 94%, three studies of 358 patients), although the difference was not statistically significant.
← all excerpts
Efficacy of progestin-primed ovarian stimulation in women with polycystic ovary syndrome undergoing <i>in vitro</i> fertilization: a systematic review and meta-analysis.
1
—
—